Intra-Cellular Therapies Inc. buy Mizuho
Start price
22.04.24
/
50%
€70.50
Target price
22.04.25
€90.20
Performance (%)
74.47%
End price
23.04.25
-
Summary
This prediction is currently being closed. The BUY prediction by Mizuho for Intra-Cellular Therapies Inc. has seen massive gains of 74.47%. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Mizuho for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Mizuho from $82.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Mizuho for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€71.00
21.06.24
21.06.24
€93.48
21.06.25
21.06.25
73.24%
22.06.25
22.06.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.30
17.02.24
17.02.24
€76.07
17.02.25
17.02.25
76.05%
18.02.25
18.02.25

